Kristin Lane - Mar 3, 2025 Form 4 Insider Report for CRH PUBLIC LTD CO (CRH)

Signature
/s/ Cot Eversole, Attorney-in-Fact for Kristin Lane
Stock symbol
CRH
Transactions as of
Mar 3, 2025
Transactions value $
-$501,649
Form type
4
Date filed
3/5/2025, 04:30 PM
Previous filing
Jan 2, 2025
Next filing
May 15, 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRH Ordinary Shares Award $0 +12.8K +55439.13% $0.00 12.8K Mar 3, 2025 Direct F1
transaction CRH Ordinary Shares Tax liability -$502K -5.02K -39.28% $99.97 7.76K Mar 3, 2025 Direct F2
holding CRH Ordinary Shares 374 Mar 3, 2025 401(k) Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRH Deferred Share Award Award +1.11K 1.11K Mar 3, 2025 Ordinary Shares 1.11K $0.00 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the vesting and release of awards granted in 2022 under the 2014 Performance Share Plan Rules on March 3, 2025 (including the award of 1,069 additional Ordinary Shares as dividend equivalents), pursuant to certification of the achievement of pre-established performance goals by the Compensation Committee of the Board of Directors of the Issuer (the "Compensation Committee").
F2 Mandatory withholding of sufficient Ordinary Shares to cover applicable tax liabilities arising in connection with the aforementioned award.
F3 Reflects time-based conditional awards, as defined in the 2014 Deferred Share Bonus Plan (the "DSB Plan Rules"), of which, subject to the determination of the Compensation Committee, the balance will vest in March 2028. In accordance with the DSB Plan Rules, dividend equivalents will apply to the Award and, to the extent awarded, will be reported at the time of vesting.